Intellia Therapeutics, Inc.

NTLA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 6, 2026 4
144 Oct 5, 2026
8-K Sep 8, 2026 8-K
8-K Sep 4, 2026 8-K
4 Aug 24, 2026 4
144 Aug 20, 2026
SCHEDULE 13G Aug 7, 2026
10-Q Aug 6, 2026 10-Q
8-K Aug 6, 2026 8-K
4 Jul 24, 2026 4
4 Jul 6, 2026 4
4 Jul 6, 2026 4
144 Jul 2, 2026
8-K Jun 15, 2026 8-K
4 Jun 10, 2026 4
4 Jun 10, 2026 4
4 Jun 10, 2026 4
4 Jun 10, 2026 4
4 Jun 10, 2026 4
4 Jun 10, 2026 4
4 Jun 10, 2026 4
8-K Jun 10, 2026 8-K
10-Q May 11, 2026 10-Q
8-K May 11, 2026 8-K
8-K Apr 30, 2026 8-K
← Newer Page 1 of 29 · 717 filings Older →